Poseida Therapeutics, Inc. financial data

Symbol
PSTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
9390 Towne Centre Drive, Suite 200, San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 283 % -48.8%
Debt-to-equity 205 % +127%
Return On Equity -121 % -622%
Return On Assets -39.7 % -351%
Operating Margin -134 % -628%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97.1M shares +11.7%
Common Stock, Shares, Outstanding 97.1M shares +11.7%
Entity Public Float 123M USD +22.9%
Common Stock, Value, Issued 10K USD +11.1%
Weighted Average Number of Shares Outstanding, Basic 97M shares +11.7%
Weighted Average Number of Shares Outstanding, Diluted 97M shares +11.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 88.5M USD -43.6%
Research and Development Expense 168M USD +14.8%
General and Administrative Expense 38.9M USD -0.78%
Operating Income (Loss) -118M USD -311%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -31.7M USD -145%
Income Tax Expense (Benefit) 107K USD -57.5%
Net Income (Loss) Attributable to Parent -113M USD -286%
Earnings Per Share, Basic -1.17 USD/shares -2825%
Earnings Per Share, Diluted -1.17 USD/shares -2825%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30.5M USD -38.8%
Cash, Cash Equivalents, and Short-term Investments 238M USD +10.8%
Accounts Receivable, after Allowance for Credit Loss, Current 12.4M USD +4.38%
Assets, Current 254M USD +10.5%
Property, Plant and Equipment, Net 17.8M USD -15.5%
Operating Lease, Right-of-Use Asset 20M USD -14.7%
Intangible Assets, Net (Excluding Goodwill) 1.32M USD 0%
Goodwill 4.23M USD 0%
Other Assets, Noncurrent 1.08M USD +1.5%
Assets 299M USD +6.21%
Accounts Payable, Current 2.99M USD +42.6%
Employee-related Liabilities, Current 7.88M USD +14.8%
Liabilities, Current 102M USD +105%
Deferred Income Tax Liabilities, Net 55K USD 0%
Operating Lease, Liability, Noncurrent 18.8M USD -17.5%
Other Liabilities, Noncurrent 2.9M USD +23%
Liabilities 238M USD +63%
Accumulated Other Comprehensive Income (Loss), Net of Tax -82K USD +70.7%
Retained Earnings (Accumulated Deficit) -650M USD -21%
Stockholders' Equity Attributable to Parent 60.8M USD -55.1%
Liabilities and Equity 299M USD +6.21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.1M USD +60.2%
Net Cash Provided by (Used in) Financing Activities -43K USD -104%
Net Cash Provided by (Used in) Investing Activities 24M USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 97.1M shares +11.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.83M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.01M USD +10.1%
Deferred Tax Assets, Valuation Allowance 201M USD +24.2%
Deferred Tax Assets, Gross 210M USD +22.4%
Operating Lease, Liability 24.9M USD -13.3%
Payments to Acquire Property, Plant, and Equipment 130K USD -83.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -113M USD -283%
Lessee, Operating Lease, Liability, to be Paid 30.9M USD -16.5%
Property, Plant and Equipment, Gross 39.3M USD +5.62%
Operating Lease, Liability, Current 6.04M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.11M USD -19.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.37M USD +3.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6M USD -27.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.26M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 91.3M USD +2.22%
Unrecognized Tax Benefits 15.3M USD +29.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.42M USD +3%
Operating Lease, Payments 1.5M USD -11.8%
Additional Paid in Capital 300K USD
Share-based Payment Arrangement, Expense 23.2M USD +6.49%
Interest Expense 9.01M USD -18.1%